164 related articles for article (PubMed ID: 9558371)
1. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides.
Motomura S; Motoji T; Takanashi M; Wang YH; Shiozaki H; Sugawara I; Aikawa E; Tomida A; Tsuruo T; Kanda N; Mizoguchi H
Blood; 1998 May; 91(9):3163-71. PubMed ID: 9558371
[TBL] [Abstract][Full Text] [Related]
2. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
[TBL] [Abstract][Full Text] [Related]
4. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
Pan J; Miao D; Chen L
Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
[TBL] [Abstract][Full Text] [Related]
5. Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides.
Liu C; Qureshi IA; Ding X; Shan Y; Huang Y; Xie Y; Ji M
Clin Sci (Lond); 1996 Jul; 91(1):93-8. PubMed ID: 8774266
[TBL] [Abstract][Full Text] [Related]
6. Activation of silent MDR1 genes in revertant cells by fusion with multidrug-resistant cells.
Yusa K; Tamura J; Waki A; Tsuruo T
Biochim Biophys Acta; 1995 Nov; 1269(3):260-6. PubMed ID: 7495879
[TBL] [Abstract][Full Text] [Related]
7. [Reversion Mechanism Study of PESV to Multidrug Resistance at Leukemia Stem Cell Level].
Yang XD; Shi ZX; Yan LX; Liu BS; Chen HY; Yan TG; Zhang WF; Yang X; Qin HR; Liu C; Ji HX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):867-874. PubMed ID: 30634217
[TBL] [Abstract][Full Text] [Related]
8. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
[TBL] [Abstract][Full Text] [Related]
10. Modulation of multidrug resistance with antisense oligodeoxynucleotide to mdr1 mRNA.
Sola JE; Colombani PM
Ann Surg Oncol; 1996 Jan; 3(1):80-5. PubMed ID: 8770307
[TBL] [Abstract][Full Text] [Related]
11. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
[TBL] [Abstract][Full Text] [Related]
12. A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.
Illmer T; Schaich M; Oelschlägel U; Nowak R; Renner U; Ziegs B; Subat S; Neubauer A; Ehninger G
Leuk Res; 1999 Jul; 23(7):653-63. PubMed ID: 10400187
[TBL] [Abstract][Full Text] [Related]
13. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
14. [Reversal of Drug Resistance in K562/ADM Cells Caused by RA and the Related Mechanisms].
Zhong SS; Yuan YP; Xin LY; Chen YJ; Zhang LQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1704-1709. PubMed ID: 34893097
[TBL] [Abstract][Full Text] [Related]
15. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
[TBL] [Abstract][Full Text] [Related]
16. Recovery of drug sensitivity by MS-209, a new multidrug resistance-reversing agent, on acute myelogenous leukaemic blasts and K562 cells resistant to adriamycin cell line.
Wang YH; Motoji T; Motomura S; Shiozaki H; Tsuruo T; Mizoguchi H
Eur J Haematol; 1997 Mar; 58(3):186-94. PubMed ID: 9150713
[TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
18. Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance.
Smeets ME; Raymakers RA; Vierwinden G; Pennings AH; Wessels H; de Witte T
Blood; 1999 Oct; 94(7):2414-23. PubMed ID: 10498614
[TBL] [Abstract][Full Text] [Related]
19. Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules.
Dassow H; Lassner D; Remke H; Preiss R
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):209-16. PubMed ID: 10783831
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance of acute leukemia and a strategy to overcome it.
Motoji T; Motomura S; Wang YH
Int J Hematol; 2000 Dec; 72(4):418-24. PubMed ID: 11197207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
